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 Abstract 
Recently the analytical power of the latest high throughput next generation DNA sequencing 
platforms has been used to analyse phage that have been selected from the panning of large 
combinatorial libraries displaying either peptide or antibody ligands. This process, commonly 
referred to as next generation phage display (NGPD), allows the researcher to determine the 
identity of specific phage that are being enriched against an antigen target by analysis of the 
DNA sequence encoding the displayed ligand. This method bypasses several steps in 
conventional phage panning that include laborious colony picking and functional ligand 
screening. A downside of this approach is that the only output from such experiments is the 
DNA sequence information of such enriched phage particles. In the case of peptides, the 
peptide sequence can be synthesised directly and used for further screening, however this is 
more difficult with larger antibody fragments such as ScFvs. In the case of ScFvs, their 
coding sequence would have to be fully elucidated, synthesised and re-cloned before 
expression. We describe here the application of an inverse PCR-ligation methodology that 
enables the specific recovery of ScFvs of interest from enriched sub-libraries of phage clones. 
Phagemid particles are recovered using sequence information derived from their unique 
heavy chain CDR3/FR4 domains and specific clones can be recovered irrespective of CDR3 
size and at levels of abundance that would be refractory to their discovery during 
conventional phage panning and screening. 
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1.0 Introduction 
The isolation of ligands from large combinatorial libraries is a powerful technique allowing 
the discovery of bioactive molecules with a wide range of applications including diagnostics 
and therapeutics. This technique is generally carried out within the context of a biological 
display system, and commonly these include phage, yeast or bacterial cells to display a 
functional biomolecule (Hoogenboom et al. 1998, Löfblom 2011, Gera et al. 2013). In doing 
so, the phenotype of the ligand is directly linked to its genotype, and the isolation of an 
individual clone displaying a particular binding property allows the isolation of the genetic 
sequence encoding the phenotype of interest (antibody, peptide etc). This technique has the 
potential to isolate ligands to a variety of target types from libraries that can contain billions 
of different specificities.  
In all display systems a target molecule (often a protein) is introduced in vitro to a library of 
potential binding partners in a process that is known as biopanning. During the biopanning 
steps, subsets of the library bind to the immobilised target, and after washing away non-
binders, the enriched ligands are eluted, propagated and then reintroduced into another round 
of biopanning against the same target. Iterative rounds of this biopanning can result in the 
enrichment of molecules with high specificity to the target. Individual clones of interest are 
identified by single clone screening (often by ELISA) to identify those specific clones of 
interest and isolated clones are then generally characterised by Sanger DNA sequencing.  
Antibody fragments are commonly displayed within phage-display libraries. Within these 
libraries an ScFv domain is commonly displayed as a fusion to the gene 3 protein product of 
the E. coli M13 bacteriophage. The ScFv is an engineered fusion protein comprised of 
antibody heavy and light chain variable regions which are kept in close proximity via a short 
uncharged linker peptide. ScFv libraries can have antibody diversities as large as 1011, (Lloyd 
et al. 2011) and are based on the in vitro random re-assortment of the variable heavy and light 
chains from naïve or primed immune repertoires. The ScFv is a versatile reagent, amenable 
for further engineering and has found different applications from diagnostics to therapeutics 
(Hairul Bahara et al. 2013). Antibody phage display technology can, in ideal conditions, 
deliver in just a few weeks immunoreagents to almost any target of interest. However, due to 
the iterative nature of panning experiments they often enrich for phage particles that exhibit 
some growth advantage, (for example they possess a less toxic gene product) and as such the 
sub-libraries can quickly become biased towards such parasitic clones that may not be the 
best binders or at worst may not exhibit any activity to the target. A more effective approach 
is to identify potentially enriched phage after just a single round or two of biopanning, before 
specific immunoreagents can be outgrown and lost in later rounds. Such an approach would 
be highly labour intensive if carried out by conventional colony screening and success would 
not be guaranteed even after screening large numbers of individual clones. Recently the 
application of the latest next generation DNA sequencing (NGS) platforms have 
revolutionised how we can approach the analysis of such experiments. Instead of laborious 
colony screening by immunoassay, the complete output of ligand genes from each panning 
round can now be sequenced in its entirety at low cost giving unparalleled information on the 
success of a panning experiment. Those domains within the ScFv that have the most 
diversity, and form the centre of the antigen combining site, the CDR3 domains, have been 
the sequencing target of choice for in silico identification of enriched sequences. Methods for 
the analysis of the NGS datasets are either based on the comparison of clone frequency 
within the enriched sub libraries relative to the whole library (Ravn et al 2010) or are based 
on the comparison of positive and negative panning reactions (panning the same library 
against a target and an unrelated molecule) and the generation of Z-scores representing 
individual ScFv enrichment (Zhang et al. 2012). Recently, Rebollo et al. also described using 
the frequency of motif isolation within NGS datasets to identify enriched bicyclic peptide 
binders to different protein targets (Rebollo et al. 2014). The identification of enriched 
candidate sequences is now a relatively straightforward process using published 
bioinformatics scripts. In the case of peptide library enrichment, candidate peptides can be 
identified, synthesised and then screened for binding in an appropriate assay. With ScFvs, 
which are typically comprised of around 350-400 amino acids, chemical synthesis of the 
active molecule is not economically viable if indeed technically possible. Gene synthesis of 
such a coding sequence is possible, but for a range of candidate ScFvs requiring screening it 
would be very costly. Also, this would rely on the full sequence of the whole ScFv molecule 
being known, whereas only short read sequencing data around the CDR3 region(s) is usually 
recovered from NGS data files from most of the current DNA sequencing platforms.  
Without efficient methods for the rapid and high throughput rescue of low abundance ScFv 
sequences of interest (those that may show enrichment during early library panning rounds) 
the application of NGS analysis to determine enriched ScFv-phage particles is of limited use. 
Here we demonstrate the sensitive recovery of ScFv clones within a background of sub-
library DNA. The recovery method uses an inverse PCR, self-ligation and cloning strategy 
(Hoskins et al. 2005, D’Angelo 2014) to selectively amplify the desired ScFv. Our further 
development of this methodology demonstrates that this approach can be used to recover 
ScFv clones with very short CDR3 motifs and at low levels within a sub library, in one 
instance where a clone was represented at a level of just 0.0025% of the phage population. 
This higher sensitivity compared to any previously reported method will facilitate the rescue 
of specific ScFvs identified from NGS datasets of panning experiments for the rapid isolation 
of the best immunoreagents, and not just those that have selective growth advantages. 
    
2.0 Materials and methods 
2.1 ScFv antibodies: All ScFv sequences originated from the MRC Griffin-1 phagemid 
library. The sub-libraries of phage were generated from the selection of this library against 
different target proteins, across several experiments. Next generation sequencing datasets 
were from Ion Torrent PGM sequence analysis using a 318 chip. ScFv sequences that were 
identified and rescued (table 1) were from multiple panning experiments and different 
panning rounds. In addition, an ScFv clone (DU15-2) isolated using colony screening was 
used as a control ScFv for method development, this ScFv was isolated as a potential binder 
to the N-terminal Dusp-Ubl domains of human USP15 cysteine protease (Ubiquitin specific 
protease 15).  
2.2 Inverse PCR of target ScFv-containing phagemid: Inverse PCR was carried out using 
primers designed to encompass the upstream region of the ScFv heavy chain CDR3 coding 
region identified during the sequencing of clones after panning. This was paired with another 
oligonucleotide annealing to the complementary DNA strand within the ScFv heavy chain 
framework region 4 (FR4; figure 1). Taking into account the degeneracy of the FR4 within 
the ScFv library, universal FR4 primers were synthesised based on the alignment of several 
FR4 domains from individual clones within the V-BASE database. The oligonucleotide 
complimentary to the FR4 domain was TGGGGCCRDGGNACMMYGGTCAC. Where 
CDR3s were very small, the 5’ end of the CDR3 specific primer was designed to be 
complimentary to sequence within the FR4 region (figure 1). In these instances a clone 
specific FR4 primer was used that was complementary to a region adjacent to the CDR3/FR4 
primer (ScFv 9 and ScFv 11, figure 1). These PCR primer sets direct the amplification of the 
entire ScFv containing phagemid of interest. In order to facilitate the blunt end cloning of 
these amplified fragments, each oligonucleotide was phosphorylated at the 5’ end. Inverse 
PCR reactions consisted of 200 µM dNTP mix, 5 pmol of each primer, and 1 unit of Q5 DNA 
polymerase (NEB) plus 10µl of GC enhancer buffer, and 10-30 ng of DNA template in a final 
volume of 50 µl of 1X Q5 reaction buffer. PCR was carried out as follows: samples were ‘hot 
started’ by heating the thermocycler to 95 °C, before the addition of samples, whereupon 
samples were initially denatured for 2 min at 95 °C, and then given a first step of 10 or 15 
cycles of 30 s annealing at between 53 - 65 °C (depending on the Tm of the primers) 
followed by 25 or 20 cycles respectively at a higher annealing temperature, compared to the 
first step, that varied from 60 to 68 °C; each cycle commenced with a 30 s denaturation step 
at 95 °C and the extension step was consistently performed at 72 °C for 5 min.  
In testing this methodology a previously characterised ScFv (DU15-2) was used. Inverse 
PCR using the specific DU15-2 primer and the FR4-L degenerate primer (figure 1) was 
carried out using a dilution series of the monoclonal phagemid spiked into 10 ng of the 
Griffin-1 library DNA. 
2.3 Cloning PCR products: PCR products were visualised by running the whole reaction 
product on a 1% TAE agarose gel stained with NANC520. Bands of the correct size were 
excised and purified using a Nucleospin DNA purification protocol. Amplified products 
contain two 5’ phosphate groups making the PCR product amenable for self-ligation. 
Ligations were carried out overnight at room temperature using 6 µl of purified PCR product, 
400U T4 DNA ligase (NEB), in a final volume of 20 µl of 1X DNA ligase buffer. The 
ligation products (2 µl) were transformed into TG1 E. coli heat shock competent cells and 
were selected on LB-Amp agar plates overnight at 37 °C. Colonies were picked and used for 
PCR screening using the CDR3 specific primer and the primer VHFR2Den (a degenerate 
framework 2 primer: 5’GGVMARGGNCTKGASTGG 3’), binding to a sequence within the 
Griffin-1 library FR2 region. Positive clones identified by PCR then had the ScFv domain 
fully sequenced by Sanger sequencing using a commercial service.  
3.0 Results 
Using phagemid DNA of a defined ScFv that had been isolated by conventional colony 
screening and previously sequenced (DU15-2), we determined that the inverse PCR methods 
could generate PCR products of a size that corresponded to that of the linear ScFv phagemid 
(figure 2A). In order to determine how sensitive this PCR based methodology was, DNA 
from DU15-2 was serially diluted into DNA extracted from the MRC Griffin-1 ScFv library. 
PCR products analysed by agarose gel determined that this inverse PCR could successfully 
amplify specific ScFv clone DNA that was present at an amount equivalent to 0.026% of the 
total DNA in the PCR; a dilution of 1 in 3,846 (figure 2A). At each DNA dilution PCR 
products were excised from the agarose, purified and self-ligated. Transformation of these 
ligation products resulted in a high number of transformants. Transformants were screened by 
colony PCR using the CDR3 specific oligonucleotide paired with a degenerate primer that 
annealed to the FR2 region within the ScFv library. From the lowest amount of template 
spike that was amplified (1 in 3,846) we achieved a colony screen success rate of 100% (10 
positive PCRs out of 10 reactions) that gave a PCR product corresponding to the expected 
amplicon size (data not shown). Of these colonies, three were further analysed by Sanger 
DNA sequencing, and all three clones were confirmed as containing the correct DU15-2 
antibody sequence. 
To demonstrate the further applicability of this technique to antibody clone rescue, where 
clones of interest may exist at very different frequencies and will possess very different heavy 
chain CDR3 sequences (both sequence composition and length), twelve ScFv clones were 
targeted from different panning experiments (table 1). These ScFvs represent a diversity of 
different length heavy chain CDR3 and clone abundance within the library. ScFvs with short 
heavy chain CDR3 domains (ScFvs 9 and 11) were amplified using primers which extended 
into the FR4 domain and the FR4-specific primer was shifted by an equal number of bases 
into the FR4 region (table 1, figure 1). For each ScFv a PCR product was obtained (examples 
given in figure 2C). In all cases self-ligation of the PCR product followed by transformation 
into TG1 cells resulted in successful recovery of clones of correct DNA sequence to the 
desired ScFv as determined by Sanger sequencing. To demonstrate the sensitive recovery of 
ScFv clones containing shorter heavy chain CDR3 domains is also achievable using this 
method we also show the recovery by inverse PCR of DNA from clone 11 DNA at a dilution 
of 0.026% of the library DNA (Figure 2B). 
 
4.0 Discussion 
The recovery of ScFv clones is a major bottleneck to the utilisation of data derived from the 
next generation DNA sequencing analysis of phage-ScFv library panning. To date, several 
methodologies have been described for the rescue of specific ScFvs from enriched libraries. 
The method described by Zhang et al. (2012) uses a biotinylated oligonucleotide 
complimentary to the heavy chain CDR3 ssDNA of the phage DNA. Once ssDNA is 
enriched with this primer using capture on streptavidin coated beads it is converted to dsDNA 
and then used to transform E. coli. Another method described by Ravn et al. (2010) used the 
heavy chain CDR3 sequence to amplify and recover ScFvs of interest using a two step PCR 
approach. Two PCRs were used to isolate DNA for the VH and VL domains of the ScFv, 
these were then assembled using a separate overlap PCR via the specific heavy chain CDR3 
region. The cloning of this PCR product back into the library vector allowed the selection of 
the specific clones of interest. This cloning rescue strategy requires 3 PCR steps, and the 
necessary restriction digestion of this DNA before ligation. Both of these described methods 
are more complicated, require additional steps and will be more costly than the inverse PCR 
methodology described here. These two publications do not determine the sensitivity of the 
methods by rescuing serial dilutions of clones within background library DNA, however 
Zhang et al. recovered specific ScFv clones of interest at a level of 1% within background 
library DNA, and Ravn et al. rescued clones to around 0.5% of the library. 
Recently, D’Angelo et al. (2014) have described a similar inverse PCR methodology to that 
detailed within the current paper. Both of these methods are a further application of SLIP- 
self ligation of inverse PCR products, developed by Hoskins et al. (2005) for the recovery of 
specific clones from drosophila cDNA libraries. D’Angelo and co-workers describe the 
rescue of ScFv clones by inverse PCR using specific PCR primers and demonstrate that this 
method was able to detect clones that were present at a level of 1.9% of the library, and 
suggest that they could isolate clones present at a levels down to 0.5% of the library. Their 
method uses two primers annealing to adjacent sequences within the HCDR3 and extending 
outwards into the framework regions. These FR-complementary 3’ regions of the primers 
will be common to many ScFv clones and it is assumed that specificity of the primers for the 
target HCDR3 is due to their higher overall homology to that particular clone. It is likely 
therefore that the method will be more efficient for larger HCDR3s where the non-specific, 
FR-complementary 3’ regions are proportionally less of the overall primer sequence. Here, 
we describe further developments of this technique to isolate ScFvs with a far greater 
sensitivity than any method reported previously. The reported method uses a single primer 
that is complementary to the HCDR3 along with a primer complementary to FR4. The FR4 
primer is likely to be shared by numerous ScFv clones. However, the HCDR3 primer, 
including its 3’ end, does not extend into common FR sequence allowing very high 
specificity in its annealing to, and extension of the target HCDR3 and therefore affording 
high specificity and concomitant efficiency in the overall inverse PCR rescue process. Using 
2 characterised ScFv sequences with HCDR3 lengths of 11 and 5 amino acids spiked into 
ScFv library DNA, we could recover the clones when present at a level of 0.026% of the total 
DNA. At this level within the sub-library, over 3800 colonies would have to be picked and 
individually screened to pick up a single clone by conventional colony screening. When we 
sought to further characterise clones of interest that were identified from sub-libraries from 
panning we were able to rescue one ScFv clone that was present at a level of 0.0025% of the 
library, or a frequency of ~1 in 40,000. Again, at this level, it would be impractical to use 
conventional colony picking and screening to isolate such a clone. The application of the 
presented methodology to the rescue of ScFv clones identified during NGPD experiments 
could be applied to early panning rounds facilitating the rescue of very low frequency 
antibodies which may not be efficient at propagation and may be lost on further rounds of 
selection. 
We have demonstrated that this phage rescue methodology can also be applied to the 
recovery of ScFvs with virtually any length of heavy chain CDR3. In the examples described 
within this paper the smallest CRD3 domain recovered coded for just 4 amino-acids. Overall, 
all 12 of the targeted ScFv clones were successfully rescued after minimal optimisation of the 
standard PCR conditions and they were present over a wide range of frequencies in the 
enriched library pool (0.0025- 53.9%). The data demonstrates the applicability of the method 
to rescue a wide range of ScFvs present at even very low frequencies.  
5.0 Conclusions: The self-ligation of inverse PCR products directed by primers homologous 
to the heavy chain CDR3 and framework 4 regions of the ScFv sequence has proven to be a 
sensitive and robust methodology for the rescue of ScFvs, even when small CDR3 domains 
are present and when ScFv clones are at very low abundance within enriched libraries. The 
methodology finally allows a significant bottleneck to be overcome in the application of 
NGPD approaches for ScFv isolation. 
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Table 1: ScFvs targeted for recovery are listed in order of their frequency within their 
appropriate sub-library. 
ScFv CDR3 Sequencea Frequency Total clone no. Percentage 
Frequencyb 
1 NLWSPFDY 35315 65438 53.9 
2 GKRYFDWFPLYHFDH 46154 97641 47.2 
3 CLNSSMTS 41651 97641 42.6 
4 MAYHTAPK 20525 61071 33.6 
5 SKTLNLSKTL 19299 80972 23.8 
6 ATSTEGDRGLFK 10446 65438 15.9 
7 LSQGLAEQYAG 7691 51594 14.9 
8 STRQSTL 3338 61071 5.4 
9 INYD 2166 60141 3.6 
10 LGRLARG 754 60141 1.2 
11 SSNTF 108 60141 0.1 
12 GGPAGYSNA 3 115541 0.0025 
a The amino acid sequence of the heavy chain CDR3 
b Frequency is the number of times this clone was sequenced compared to the total number of 
clones sequenced within that sequencing experiment. 	  
Figure legends	  
Figure 1: Inverse PCR schematic. Inverse PCR was used to amplify the whole ScFv clone of 
interest. The DU15-2 ScFv illustrates the primer design strategy for those ScFvs with 
relatively long heavy chain CDR3 domains, here the reverse primer is complementary to the 
whole CDR3 coding sequence, and is paired with a forward FR4 primer that abuts the 5’ end 
of the reverse primer. ScFvs with relatively short heavy chain CDR3 (ScFv 9 and 11) used a 
reverse primer which encompassed all of the unique ScFv heavy chain CDR3 sequence to 
direct the specific amplification of the correct ScFv, but this also included sequence from the 
FR4 domain as illustrated. A forward primer is designed that anneals to the heavy chain FR4 
domain to the immediate border of the reverse primer. Both primers were 5’ phosphorylated 
(P). 
Figure 2: Inverse PCR products of ScFv that had been spiked into a background of 20 ng 
MRC Griffin-1 library DNA. (A) The rescue of DU15-2 ScFv (containing an 11 amino acid 
heavy chain CDR3); 1: positive control amplification containing 10 ng DU15-2 phagemid 
DNA, 2: 0.53 ng DU15-2 DNA spiked into library, 3: 0.053 ng DU15-2 DNA spiked into 
library, 4: 0.0053 ng DU15-2 DNA spiked into library. (B) The phagemid DNA of clone 11 
(with a 5 amino acid heavy chain CDR3) was also diluted into a background of Griffin 1 
library (B) lanes 1-4, as for the DU15-2 phagemid. (C) Examples of PCR products from the 
inverse PCR amplifications used for each ScFv rescue. Amplified products are identified by 
their clone number (as detailed in table 1). Samples were analysed on a 1% (w/v) agarose gel, 
M- 1kb DNA markers (NEB), in A and B arrow indicates full length ScFv products that were 
excised, re-ligated and then transformed. 
  
	  Figure 1 
 
 
 
 
  
Figure 2 
A                                     B 
 
 
C 
 
  
Graphical abtract: 
 
 
 
 
1.#ScFV#clone#iden.ﬁed#by#NGS#of#HCDR3#domain#
#2.#Phosphorylated#inverse#PCR#primers#designed#to#HCDR3#and#
######FR4#regions#within#the#speciﬁc#ScFv#of#interest#
#3.#Inverse#PCR#to#speciﬁcally#amplify#the#target#phagemid#DNA#
clone#
4.#Religa.on#of#the#PCR#product,#cloning#and#sequencing#
